🇺🇸 FDA
Pipeline program

Exparel

18-133

Approved small_molecule completed

Quick answer

Exparel for Analgesia, Postoperative is a Approved program (small_molecule) at Pacira BioSciences with 1 ClinicalTrials.gov record(s).

Program details

Company
Pacira BioSciences
Indication
Analgesia, Postoperative
Phase
Approved
Modality
small_molecule
Status
completed

Clinical trials